参考文献

1.Mason BJ，Quello S，Shadan F.Gabapentin for the traetmnt of alcohol use disorder.Expert Opin Invesig Drugs，2018，27（1）：113-124

2.Lieber CS.Alcohol and the liver： Metabolism of alcohol and itsrole in hepatic and extrahepatic diseases.Mt Sinai J Med，2000，67：84-94

3.Husemoen LL，Fenger M，Friedrich N，et al.The association of ADH and ALDH gene variants with alcohol drinking habitsand cardiovascular disease risk factors.Alcohol Clin Exp Res，2008，32：1984-1991

4.Steensland P，Simms JA，Holgate J，et al.Varenicline，and α4β2 nicotinic acetylcholine receptor partial agonist，selectivelydecreases ethanol consumption and seeking.Proc Natl AcadSci USA，2007，104：12518-12523

5.Hutchison KE，Haughey H，Niculescu M，et al.The incentivesalience of alcohol： Translating the effects of genetic variant in CNR1.Arch Gen Psychiatry，2008，65：841-850

6.Sakurai S，Cui R，Tanigawa T，et al.Alcohol consumption beforesleep is associated with severity of sleep-disordered breathingamong professional Japanese truck drivers.Alcohol Clin ExpRes，2007，31：2053-2058

7.Stephens R，Ling J，Heffernan TJ，et al.A review of the literatureon the cognitive effects of alcohol hangover.Alcohol Alcohol，2008，43：163-170

8.Urbano-Marquez A，Estruch R，Fernandez-Sola J，et al.Thegreater risk of alcoholic cardiomyopathy and myopathy inwomen compared with men.JAMA，1995，274：149-154

9.Lieber CS.Gastric ethanol metabolism and gastritis： Interactionswith other drugs，Helicobacter pylori，and antibiotic therapy（1957～1997）： A review.Alcohol Clin Exp Res，1997，21：1360-1366

10.Alvisa-Negrin J，Gonzalez-Reimers E，Santolaria-Fernandez F，et al.Osteopenia in alcoholics：Effect of alcohol abstinence.Alcohol Alcoholism，2009，44：468-475

11.Wartenberg AA.Management of common medical problems.In，Principles of Addiction Medicine，2d ed.（Graham AW andShultz TK，eds.）American Society of Addiction Medicine，Chevy Chase，MD，1998，731-740

12.Schuckit MA.An overview of genetic influences in alcoholism.J Substance Abuse Treat，2009，36：S5-S14

13.Johnson BA，Ait-Daoud N，Bowden CL，et al.Oral topiramatefor treatment of alcohol dependence：A randomized，controlledtrial.Lancet，2003，361：1677-1685

14.Lee YK，Chin YW，Bae JK，et al.Pharmacokinetics of isoliquiritigenin and its metabolites in rats：low bioavailability is primarily due to the hepatic and intestinal metabolism.Planta Med.2013 Nov； 79（17）：1656-1665

15.Peng F，Du Q，Peng C，et al.A Review： The Pharmacology of Isoliquiritigenin.Phytother Res，2015，29（7）：969-977

16.Hosseinzadeh H，Nassiri-Asl M.Pharmacological Effects of Glycyrrhiza spp.and Its Bioactive Constituents： Update and Review.Phytother Res，2015，29（12）：1868-1886

17.Li K，Ji S，Song W，et al.Glycybridins A-K，Bioactive Phenolic Compounds from Glycyrrhiza glabra.J Nat Prod，2017，80（2）：334-346 bFIEeSbFI3mrbHvpizbZ1y38HXAbbpgyNfxrjjcCwra2KmI9PDVPp2lsOB+eTpP6